| 000 | 01625 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516153419.0 | ||
| 264 | 0 | _c20131231 | |
| 008 | 201312s 0 0 eng d | ||
| 022 | _a1424-3997 | ||
| 024 | 7 |
_a10.4414/smw.2013.13783 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLienert, Carmen | |
| 245 | 0 | 0 |
_aTolerance of intravenous methylprednisolone for relapse treatment in demyelinating CNS disease. _h[electronic resource] |
| 260 |
_bSwiss medical weekly _c2013 |
||
| 300 |
_aw13783 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aActigraphy |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aDemyelinating Autoimmune Diseases, CNS _xdrug therapy |
| 650 | 0 | 4 |
_aDepression _xchemically induced |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethylprednisolone _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 |
_aSleep Initiation and Maintenance Disorders _xchemically induced |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aSchawalder, Gabriela | |
| 700 | 1 | _aFindling, Oliver | |
| 700 | 1 | _aKamm, Christian P | |
| 700 | 1 | _aHumpert, Sebastian | |
| 700 | 1 | _aMugglin, Anne | |
| 700 | 1 | _aMathis, Johannes | |
| 700 | 1 | _aSturzenegger, Mathias | |
| 700 | 1 | _aMattle, Heinrich P | |
| 773 | 0 |
_tSwiss medical weekly _gvol. 143 _gp. w13783 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.4414/smw.2013.13783 _zAvailable from publisher's website |
| 999 |
_c22811803 _d22811803 |
||